ImmunityBio (IBRX) Sales Jump 121% as Its Cancer Drug Gets a Bigger Playing Field
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Browsing Tag